4.6 Article

Prediction of the mechanisms of action of Qutan Huoxue decoction in non-alcoholic steatohepatitis (NASH): a network pharmacology study and experimental validation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Network pharmacology: curing causal mechanisms instead of treating symptoms

Cristian Nogales et al.

Summary: For complex diseases, the traditional approach of drug discovery is highly ineffective. The shift towards systems and network medicine, along with the use of network pharmacology, revolutionizes the way we define, diagnose, and treat diseases. This approach focuses on causal, multitarget signaling modules, allowing for precise and effective therapeutic intervention through drug repurposing.

TRENDS IN PHARMACOLOGICAL SCIENCES (2022)

Review Biochemistry & Molecular Biology

TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling

Anna Ciesielska et al.

Summary: This article discusses the role of TLR4 in promoting inflammatory responses, including internalization and intracellular trafficking of exogenous endotoxin and bacteria. The authors emphasize the significant impact of internalization rate and endo-lysosomal compartment transport rate on inflammatory responses.

CELLULAR AND MOLECULAR LIFE SCIENCES (2021)

Review Gastroenterology & Hepatology

Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention

Daniel Q. Huang et al.

Summary: The prevalence of NAFLD-related HCC is projected to continue rising globally, with NASH expected to increase and obesity as a major risk factor. Urgent measures are needed to address this growing problem.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Chemistry, Medicinal

Poria cocos polysaccharides reduces high-fat diet-induced arteriosclerosis in ApoE-/- mice by inhibiting inflammation

Weifeng Li et al.

Summary: Poria cocos polysaccharides can intervene in atherosclerosis by reducing inflammatory factors and blood lipid levels.

PHYTOTHERAPY RESEARCH (2021)

Article Multidisciplinary Sciences

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Dominik Pfister et al.

Summary: The study investigated the impact of NASH on immunotherapy response in HCC patients and found that NASH-HCC may be less responsive to immunotherapy. Aberrant T cell activation caused by NASH-related tissue damage led to impaired immune surveillance in HCC patients.

NATURE (2021)

Article Cell Biology

Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis

Junjie Yu et al.

Summary: Elevated hepatocyte Jagged1 expression plays a crucial role in Notch-induced liver fibrosis in NASH. Inhibition of Jagged1 may serve as a potential therapeutic target for patients with NASH.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Cell Biology

Gut-Liver Axis: Liver Sinusoidal Endothelial Cells Function as the Hepatic Barrier in Colitis-Induced Liver Injury

Yang Wang et al.

Summary: The study found that LSEC is a crucial barrier in the gut-liver axis, defending the liver against colitis-induced injury. When LSECs are damaged, they can turn into a pro-inflammatory pattern under the stimulation of LPS. LSEC injury and colitis-derived LPS synergistically contribute to the recruitment and activation of hepatic neutrophils. Neutrophils play a pivotal role as a downstream effector in colitis-induced liver injury.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Multidisciplinary Sciences

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Dominik Pfister et al.

Summary: The text discusses the impact of NASH on the development of HCC and the effect of immunotherapy, revealing the accumulation of exhausted and unconventionally activated CD8(+)PD1(+) T cells in NASH-affected livers. In preclinical models of NASH-induced HCC, anti-PD1 treatment led to an increase in HCC, with CD8(+) T cells contributing to this increase.

NATURE (2021)

Article Medicine, Research & Experimental

α-ketoglutarate attenuates ischemia-reperfusion injury of liver graft in rats

Ming-xiang Cheng et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Article Gastroenterology & Hepatology

Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease

Jia-Min Yang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2019)

Article Medicine, General & Internal

The Future of Nonalcoholic Fatty Liver Disease Treatment

Khurram Mazhar

MEDICAL CLINICS OF NORTH AMERICA (2019)

Review Gastroenterology & Hepatology

The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Konstantin Kazankov et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Review Gastroenterology & Hepatology

Current and future pharmacological therapies for NAFLD/NASH

Yoshio Sumida et al.

JOURNAL OF GASTROENTEROLOGY (2018)

Review Gastroenterology & Hepatology

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

Zobair Younossi et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Multidisciplinary Sciences

The molecular basis of JAK/STAT inhibition by SOCS1

Nicholas P. D. Liau et al.

NATURE COMMUNICATIONS (2018)

Article Gastroenterology & Hepatology

Therapies in non-alcoholic steatohepatitis (NASH)

Abdul M. Oseini et al.

LIVER INTERNATIONAL (2017)

Article Medicine, Research & Experimental

TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival

Auvro R. Mridha et al.

CLINICAL SCIENCE (2017)

Article Medicine, Research & Experimental

Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression

Masashi Miyao et al.

LABORATORY INVESTIGATION (2015)

Article Biochemistry & Molecular Biology

Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-induced Mouse Model through Tumor Necrosis Factor-α Production

Annie-Carole Tosello-Trampont et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Review Gastroenterology & Hepatology

SOCS1, a Negative Regulator of Cytokine Signals and TLR Responses, in Human Liver Diseases

Minoru Fujimoto et al.

GASTROENTEROLOGY RESEARCH AND PRACTICE (2010)

Review Biochemistry & Molecular Biology

Bilirubin: an endogenous scavenger of nitric oxide and reactive nitrogen species

Cesare Mancuso et al.

REDOX REPORT (2006)